Vitamin B1 in Research and Pharmaceuticals: Stability, Bioavailability and Industrial Relevance
Vitamin B1 (thiamine) is one of the key micronutrients involved in energy metabolism. At the same time, it is an indispensable cofactor in numerous enzymatic reactions. In research and pharmaceutical development, the active ingredient plays a far greater role than is often assumed.
Biochemical significance of Vitamin B1
In the body, thiamine is converted into thiamine pyrophosphate (TPP), one of the key substances in carbohydrate metabolism. TPP functions, among other roles, as a cofactor in the following enzyme complexes:
• Pyruvate dehydrogenase complex
• α ketoglutarate dehydrogenase complex
• Transketolase of the pentose phosphate pathway
These systems are directly involved in ATP production, the maintenance of neuronal energy metabolism, and the synthesis of neurotransmitters and nucleotides. Thiamine deficiencies are noticeable. Nerve cells in particular are sensitive, making Vitamin B1 an interesting subject for neurological and metabolic research.
Pharmaceutical companies also use thiamine and its derivatives for various therapeutic applications, for example:
• in the treatment of thiamine deficiency resulting from alcohol dependence or malnutrition,
• as supportive therapy for polyneuropathies,
• in metabolic disorders,
• in cardiology for deficiency states accompanying heart failure.
Thiamine is compatible with a wide range of excipients. New research initiatives focus on thiamine derivatives that offer even better bioavailability and stability and reach specific cellular targets. It can be reliably integrated into industrial processes, both in high purity pharmaceutical contexts and as a functional raw material for biotechnological applications.
4c media